The gene TP53 is mutated in a third of human cancers [11] to silence this tumor suppressive pathway, which similarly is known to promote cancer in both mouse [12] and porcine [13] genetic models as well as in human cells [9], and is associated with the cancer predisposition Li-Fraumeni Syndrome [14]. Here, TP53 is linked to cancer.